Combination of human cytomegalovirus recombinant immediate-early protein (IE1) with 80 nm cationic biovectors: protection from proteolysis and potentiation of presentation to CD4+ T-cell clones in vitro

This publication has 22 references indexed in Scilit:

• Analysis of the Proliferative T Cell Response to Human Cytomegalovirus Major Immediate‐Early Protein (IEl): Phenotype, Frequeney and Variability*
  Scandinavian Journal of Immunology, 1995
• Formulation Of An Immunogenic Human Cytomegalovirus Vaccine: Responses In Mice
  The Journal of Infectious Diseases, 1995
• Stabilization and enhancement of interleukin-2 in vitro bioactivity by new carriers: supramolecular biovectors
  Vaccine, 1994
• MULTICENTER TRIAL OF TOWNE STRAIN ATTENUATED VIRUS VACCINE IN SERONEGATIVE RENAL TRANSPLANT RECIPIENTS
  Transplantation, 1994
• Vaccines for varicella-zoster virus and cytomegalovirus: recent progress
  Science, 1994
• Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8⁺ virus‐specific cytotoxic T lymphocytes
  Journal of Medical Virology, 1994
• Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
  Science, 1992
• The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody Status
  New England Journal of Medicine, 1992
• Isolated gA/gB glycoprotein complex of human cytomegalovirus envelope induces humoral and cellular immune-responses in human volunteers
  Vaccine, 1990
• Expression of the acidic nuclear immediate-early protein (IE1) of human cytomegalovirus in stable cell lines and its preferential association with metaphase chromosomes
  Virology, 1989